DDX5 and malignant colon neoplasm: On the other hand, a treatment with oxaliplatin, an anticancer drug classified as a platinum preparation, phosphorylates DDX5 at T564 and/or T446 via p38, thereby inducing apoptosis in colon cancer cells [58].